Lifeline Biotechnologies Inc (LLBO)

[confirm]

Launch announcement exerts:


Reno, NV , Feb. 28, 2018 (GLOBE NEWSWIRE) --
Lifeline Biotechnologies, Inc, (“The Company”) (OTC PINK: LLBO) Provides Information to the Public and Updates It’s Shareholders.
Jim Holmes, Lifeline’s Cyrcadia Health CEO commented “After over 20 years of product development, testing and validation, over $20 million of investment, 2018 is scheduled and expected to be the first year of sales of our potentially lifesaving product. Our tested and proven technology, from our multiple rounds of clinical trials, has shown early identification of breast tissue abnormalities, many of which could lead to cancers, potentially can save lives and costs.”


Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter
by admin | Feb 21, 2018 | News |
“Our priority now is to finalize and implement our marketing plan enabling the ramp up of sales as soon as possible in 2018 upon product delivery.”
“On behalf of the Cyrcadia, Inc. team, we thank you for your support as we bring this life saving technology to market. We will make every effort to ensure timely and profitable delivery of CI’s technology to the “U.S. market”and rest of world outside of the territories covered by CA.”
Sincerely,
Matt Benardis
CEO
Cyrcadia, Inc


Rob Royea Cyrcadia Asia CEO: Jan 2019 launch interview
Oct 31 2018: (I believe part 2 is Jan launch discussion)
https://cyrcadia.asia/2018/10/31/hkibc-all-about-money-features-rob-royea-cyrcadia-asia/#more-676




Reno, NV May 29, 2018, Cyrcadia Health “B” Warrant Acceleration Option
by admin | May 29, 2018 | News
Based on 2018 Go-To-Market plans, investment infusion is paramount in keeping on track and maintaining our accelerated pace. Our stakeholders have been essential in supporting our march to bring the most advanced Breast Health product to market.
“Principals of these companies have been involved with Cyrcadia Health for a number of years and have a deep understanding of our value proposition to bring significant value to our Go-To-Market launch,” says Matt Benardis, CEO.

May 4, 2018, Reno, NV. Expanded Go-To-Market Team
by admin | May 4, 2018 | News
Cyrcadia, Inc. is pleased to announce the addition of Marly Heidkamp, Chief Operating Officer, R.N., MSEd to the executive team to focus on execution of the Go-to- Market plan. Jim Holmes, CFO, say, “We are pleased to have an operations executive join our team who possesses medical product management experience as well. We are confident her leadership will bring added perspective to a product targeted for the female population.” Matt Benardis, CEO, added “We have already seen results from her leadership of the recent kick-off meeting with the comprehensive Go-To- Market team and her engagement of each department regarding oversight, organization and accountability.”

The human element of IoE changing the way breast cancer is detected
TechNovember 03, 2015 08:47
By Vatsun Thirapatarapong
10,540 Viewed
exerts-
Cisco and Cyrcadia Health are involved in the development of an “ iTBra”...
, iTBra will provide thousands of women with early warnings of cancer formation, enabling doctors to implement treatment plans to save lives in time.
Cisco has been following Cyrcadia Health’s efforts closely as their work is a major example of how innovation, made possible by the Internet of Everything, can change and ultimately save lives...
Cisco is chronicling the story of the iTBra by funding a documentary scheduled for release later this year...
More important, is the story of how the connected health industry – poised to be a billion market by 2018 – could change everything we know about medicine.
iTBra is only one example of the Internet of Everything at work in the healthcare industry. In the next three to five years, the number of health-related connected devices will soar. The globally connected health market will grow at an annual growth rate of 33 percent by 2019.


China's AI leader iFLYTEK invests in breast cancer detection wearable Cyrcadia Asia
2018-07-16 09:00:
exerts-
The Pre-A funding enables Cyrcadia to complete product development and launch into Hong Kong and other Asian markets in late 2018...
Commenting on the deal, Tao Xiaodong iFlytech Med Dir.,said: "We are excited to play a leading role in the development and launch of Cyrcadia's technology. iFlytek is already harnessing the power of AI in healthcare, but Cyrcadia's technology,...
As Cyrcadia's user base grows, it has the potential to be the world's largest data base of breast health and breast cancer incidence...

Asia Co-Investors Club
(Past Events)
exert-
Rob Royea, CEO of Cyrcadia Asia, shared his journey with us on 8th October, from the initial idea to the launch of a path-breaking device that has the potential to save millions of lives.


September 21, 2018
Ameing for Asia
exert-
High Demand for Breast Cancer Diagnosis and Treatment Products in Asia
iTBra, through its Hong Kong subsidiary. The company plans a further expansion into China, Indonesia, Malaysia, the Philippines, Singapore and Thailand before the end of the year...


Swiss Association & Swiss Chamber of Commerce
Joint Monthly Luncheon,
Oct8 2018
"Detected"
Guest Speaker: Rob Royea CEO, Cyrcadia Asia, Ltd.
Imagine a world where AI detects breast cancer through a bra. That world is just a “few”months away.


My dad always said read between the lines...tic toc tic...